FusionNeoAntigen Logo

Home

Download

Statistics

Examples

Help

Contact

Terms of Use

Center for Computational Systems Medicine
leaf

Fusion Gene and Fusion Protein Summary

leaf

Fusion Amino Acid Sequences (multiple BPs and multiple gene isoforms)

leaf

Fusion Protein Breakpoint Sequences - (for the Screening of the FusionNeoAntigens)

leaf

Potential FusionNeoAntigens in HLA I - (netMHCpan v4.1 + deepHLApan v1.1)

leaf

Potential FusionNeoAntigens in HLA II - (netMHCIIpan v4.1)

leaf

Fusion Breakpoint 14 AA Peptide Structure - (RoseTTAFold)

leaf

Filtering FusionNeoAntigens Through Checking the Interaction with HLAs in 3D - (Glide)

leaf

Vaccine Design for the FusionNeoAntigens (RNA/protein sequences)

leaf

Potential target of CAR-T therapy development

leaf

Information on the samples that have these potential fusion neoantigens

leaf

Fusion Protein Targeting Drugs - (Manual Curation)

leaf

Fusion Protein Related diseases - (Manual Curation)

Fusion Protein:CACNB1-PPP4C

Fusion Gene and Fusion Protein Summary

check button Fusion gene summary
Fusion partner gene informationFusion gene name: CACNB1-PPP4C
FusionPDB ID: 12393
FusionGDB2.0 ID: 12393
HgeneTgene
Gene symbol

CACNB1

PPP4C

Gene ID

782

5531

Gene namecalcium voltage-gated channel auxiliary subunit beta 1protein phosphatase 4 catalytic subunit
SynonymsCAB1|CACNLB1|CCHLB1PP-X|PP4|PP4C|PPH3|PPP4|PPX
Cytomap

17q12

16p11.2

Type of geneprotein-codingprotein-coding
Descriptionvoltage-dependent L-type calcium channel subunit beta-1calcium channel voltage-dependent subunit beta 1calcium channel, L type, beta 1 polypeptidecalcium channel, voltage-dependent, beta 1 subunitdihydropyridine-sensitive L-type, calcium channel beta-serine/threonine-protein phosphatase 4 catalytic subunitepididymis secretory sperm binding proteinprotein phosphatase 4 (formerly X), catalytic subunitprotein phosphatase X, catalytic subunit
Modification date2020031320200320
UniProtAcc

Q02641

Main function of 5'-partner protein: FUNCTION: Regulatory subunit of L-type calcium channels (PubMed:1309651, PubMed:8107964, PubMed:15615847). Regulates the activity of L-type calcium channels that contain CACNA1A as pore-forming subunit (By similarity). Regulates the activity of L-type calcium channels that contain CACNA1C as pore-forming subunit and increases the presence of the channel complex at the cell membrane (PubMed:15615847). Required for functional expression L-type calcium channels that contain CACNA1D as pore-forming subunit (PubMed:1309651). Regulates the activity of L-type calcium channels that contain CACNA1B as pore-forming subunit (PubMed:8107964). {ECO:0000250|UniProtKB:P19517, ECO:0000269|PubMed:1309651, ECO:0000269|PubMed:15615847, ECO:0000269|PubMed:8107964}.
.
Ensembl transtripts involved in fusion geneENST idsENST00000344140, ENST00000394303, 
ENST00000394310, ENST00000582877, 
ENST00000279387, ENST00000561610, 
Fusion gene scores for assessment (based on all fusion genes of FusionGDB 2.0)* DoF score16 X 13 X 5=10406 X 6 X 3=108
# samples 176
** MAII scorelog2(17/1040*10)=-2.61297687689075
possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs).
DoF>8 and MAII<0
log2(6/108*10)=-0.84799690655495
possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs).
DoF>8 and MAII<0
Fusion gene context

PubMed: CACNB1 [Title/Abstract] AND PPP4C [Title/Abstract] AND fusion [Title/Abstract]

Fusion neoantigen context

PubMed: CACNB1 [Title/Abstract] AND PPP4C [Title/Abstract] AND neoantigen [Title/Abstract]

Most frequent breakpoint (based on all fusion genes of FusionGDB 2.0)CACNB1(37339966)-PPP4C(30094715), # samples:2
Anticipated loss of major functional domain due to fusion event.CACNB1-PPP4C seems lost the major protein functional domain in Hgene partner, which is a CGC by not retaining the major functional domain in the partially deleted in-frame ORF.
CACNB1-PPP4C seems lost the major protein functional domain in Hgene partner, which is a essential gene by not retaining the major functional domain in the partially deleted in-frame ORF.
* DoF score (Degree of Frequency) = # partners X # break points X # cancer types
** MAII score (Major Active Isofusion Index) = log2(# samples/DoF score*10)

check button Gene ontology of each fusion partner gene with evidence of Inferred from Direct Assay (IDA) from Entrez
PartnerGeneGO IDGO termPubMed ID


check button Four levels of functional features of fusion genes
Go to FGviewer search page for the most frequent breakpoint (https://ccsmweb.uth.edu/FGviewer/chr17:37339966/chr16:30094715)
- FGviewer provides the online visualization of the retention search of the protein functional features across DNA, RNA, protein, and pathological levels.
- How to search
1. Put your fusion gene symbol.
2. Press the tab key until there will be shown the breakpoint information filled.
4. Go down and press 'Search' tab twice.
4. Go down to have the hyperlink of the search result.
5. Click the hyperlink.
6. See the FGviewer result for your fusion gene.
FGviewer

check buttonRetention analysis results of each fusion partner protein across 39 protein features of UniProt such as six molecule processing features, 13 region features, four site features, six amino acid modification features, two natural variation features, five experimental info features, and 3 secondary structure features, are available here.

check buttonFusion gene breakpoints across CACNB1 (5'-gene)
* Click on the image to open the UCSC genome browser with custom track showing this image in a new window.
all structure

check buttonFusion gene breakpoints across PPP4C (3'-gene)
* Click on the image to open the UCSC genome browser with custom track showing this image in a new window.
all structure


Top

Fusion Amino Acid Sequences


check buttonFusion information from ORFfinder translation from full-length transcript sequence from FusionPDB.
HenstTenstHgeneHchrHbpHstrandTgeneTchrTbpTstrandSeq length
(transcript)
BP loci
(transcript)
Predicted start
(transcript)
Predicted stop
(transcript)
Seq length
(amino acids)
ENST00000394303CACNB1chr1737339966-ENST00000279387PPP4Cchr1630094715+219412582081878556
ENST00000394303CACNB1chr1737339966-ENST00000561610PPP4Cchr1630094715+213512582081878556
ENST00000394310CACNB1chr1737339966-ENST00000279387PPP4Cchr1630094715+219312572071877556
ENST00000394310CACNB1chr1737339966-ENST00000561610PPP4Cchr1630094715+213412572071877556
ENST00000344140CACNB1chr1737339966-ENST00000279387PPP4Cchr1630094715+232913932082013601
ENST00000344140CACNB1chr1737339966-ENST00000561610PPP4Cchr1630094715+227013932082013601

check buttonDeepORF prediction of the coding potential based on the fusion transcript sequence of in-frame fusion genes. DeepORF is a coding potential classifier based on convolutional neural network by comparing the real Ribo-seq data. If the no-coding score < 0.5 and coding score > 0.5, then the in-frame fusion transcript is predicted as being likely translated.
HenstTenstHgeneHchrHbpHstrandTgeneTchrTbpTstrandNo-coding scoreCoding score
ENST00000394303ENST00000279387CACNB1chr1737339966-PPP4Cchr1630094715+0.0047205550.99527943
ENST00000394303ENST00000561610CACNB1chr1737339966-PPP4Cchr1630094715+0.0060463790.99395365
ENST00000394310ENST00000279387CACNB1chr1737339966-PPP4Cchr1630094715+0.0047175050.9952825
ENST00000394310ENST00000561610CACNB1chr1737339966-PPP4Cchr1630094715+0.0060539120.99394614
ENST00000344140ENST00000279387CACNB1chr1737339966-PPP4Cchr1630094715+0.0043035260.9956964
ENST00000344140ENST00000561610CACNB1chr1737339966-PPP4Cchr1630094715+0.0055968530.9944031

check button Predicted full-length fusion amino acid sequences. For individual full-length fusion transcript sequence from FusionPDB, we ran ORFfinder and chose the longest ORF among all the predicted ones.

Get the fusion protein sequences from here.

Fusion protein sequence information is available in the fasta format.
>FusionGDB ID_FusionGDB isoform ID_FGname_Hgene_Hchr_Hbp_Henst_Tgene_Tchr_Tbp_Tenst_length(fusion AA) seq_BP

Top

Fusion Protein Breakpoint Sequences for CACNB1-PPP4C

check button +/-13 AA sequence from the breakpoints of the fusion protein sequences.
HgeneHchrHbpTgeneTchrTbpLength(fusion protein)BP in fusion proteinPeptide
CACNB1chr1737339966PPP4Cchr16300947151257348SLAPIIVYIKITSPKVRYPDRITLIR
CACNB1chr1737339966PPP4Cchr16300947151258348SLAPIIVYIKITSPKVRYPDRITLIR
CACNB1chr1737339966PPP4Cchr16300947151393393SLAPIIVYIKITSPKVRYPDRITLIR

Top

Potential FusionNeoAntigen Information of CACNB1-PPP4C in HLA I

check button Multiple sequence alignments of the potential FusionNeoAntigens per fusion breakpoints. If the MSA is empty, then it means that there were predicted fusion neoantigens in this fusion breakpoint, but those predicted fusion neoantigens were not across the breakpoint, which is not fusion-specific.
CACNB1-PPP4C_37339966_30094715.msa

check button Potential FusionNeoAntigen Information
* We used NetMHCpan v4.1 (%rank<0.5) and deepHLApan v1.1 (immunogenic score>0.5)
Fusion geneHchrHbpTgeneTchrTbpHLA IFusionNeoAntigen peptideBinding scoreImmunogenic scoreNeoantigen start (at BP 13)Neoantigen end (at BP 13)
CACNB1-PPP4Cchr1737339966chr16300947151393HLA-B15:01KITSPKVRY0.99020.8658918
CACNB1-PPP4Cchr1737339966chr16300947151393HLA-B15:25KITSPKVRY0.98410.8722918
CACNB1-PPP4Cchr1737339966chr16300947151393HLA-B15:17KITSPKVRY0.91880.8165918
CACNB1-PPP4Cchr1737339966chr16300947151393HLA-B08:09YIKITSPKV0.90980.5022716
CACNB1-PPP4Cchr1737339966chr16300947151393HLA-A02:13YIKITSPKV0.7980.661716
CACNB1-PPP4Cchr1737339966chr16300947151393HLA-A30:08KITSPKVRY0.78790.6903918
CACNB1-PPP4Cchr1737339966chr16300947151393HLA-A32:13KITSPKVRY0.41130.8889918
CACNB1-PPP4Cchr1737339966chr16300947151393HLA-B15:03IKITSPKVRY0.95820.6616818
CACNB1-PPP4Cchr1737339966chr16300947151393HLA-A31:02VYIKITSPKVR0.99430.7943617
CACNB1-PPP4Cchr1737339966chr16300947151393HLA-C15:04ITSPKVRY0.99750.86721018
CACNB1-PPP4Cchr1737339966chr16300947151393HLA-C12:04ITSPKVRY0.91450.99241018
CACNB1-PPP4Cchr1737339966chr16300947151393HLA-B15:07KITSPKVRY0.96440.5839918
CACNB1-PPP4Cchr1737339966chr16300947151393HLA-B15:05KITSPKVRY0.69710.8675918
CACNB1-PPP4Cchr1737339966chr16300947151393HLA-C15:04KITSPKVRY0.53370.8332918
CACNB1-PPP4Cchr1737339966chr16300947151393HLA-C15:09ITSPKVRY0.99750.86721018
CACNB1-PPP4Cchr1737339966chr16300947151393HLA-C16:02ITSPKVRY0.9630.98691018
CACNB1-PPP4Cchr1737339966chr16300947151393HLA-C16:01ITSPKVRY0.92130.96191018
CACNB1-PPP4Cchr1737339966chr16300947151393HLA-B15:135KITSPKVRY0.99090.8506918
CACNB1-PPP4Cchr1737339966chr16300947151393HLA-B15:33KITSPKVRY0.99020.8658918
CACNB1-PPP4Cchr1737339966chr16300947151393HLA-B15:27KITSPKVRY0.99020.8643918
CACNB1-PPP4Cchr1737339966chr16300947151393HLA-B15:125KITSPKVRY0.99020.8658918
CACNB1-PPP4Cchr1737339966chr16300947151393HLA-B15:34KITSPKVRY0.99020.8658918
CACNB1-PPP4Cchr1737339966chr16300947151393HLA-B15:39KITSPKVRY0.9870.8022918
CACNB1-PPP4Cchr1737339966chr16300947151393HLA-A02:03YIKITSPKV0.98250.6636716
CACNB1-PPP4Cchr1737339966chr16300947151393HLA-B15:50KITSPKVRY0.97780.7985918
CACNB1-PPP4Cchr1737339966chr16300947151393HLA-B15:35KITSPKVRY0.97410.8311918
CACNB1-PPP4Cchr1737339966chr16300947151393HLA-A30:01VYIKITSPK0.96540.7774615
CACNB1-PPP4Cchr1737339966chr16300947151393HLA-B15:12KITSPKVRY0.96480.8638918
CACNB1-PPP4Cchr1737339966chr16300947151393HLA-A30:01KITSPKVRY0.81180.7914918
CACNB1-PPP4Cchr1737339966chr16300947151393HLA-A32:01KITSPKVRY0.7470.8982918
CACNB1-PPP4Cchr1737339966chr16300947151393HLA-B15:20KITSPKVRY0.70190.895918
CACNB1-PPP4Cchr1737339966chr16300947151393HLA-C15:09KITSPKVRY0.53370.8332918
CACNB1-PPP4Cchr1737339966chr16300947151393HLA-B15:54IKITSPKVRY0.94690.8386818
CACNB1-PPP4Cchr1737339966chr16300947151393HLA-B15:68IKITSPKVRY0.85870.561818

Top

Potential FusionNeoAntigen Information of CACNB1-PPP4C in HLA II

check button Multiple sequence alignments of the potential FusionNeoAntigens per fusion breakpoints. If the MSA is empty, then it means that there were predicted fusion neoantigens in this fusion breakpoint, but those predicted fusion neoantigens were not across the breakpoint, which is not fusion-specific.
CACNB1-PPP4C_37339966_30094715.msa

check button Potential FusionNeoAntigen Information
* We used NetMHCIIpan v4.1 (%rank<0.5).
Fusion geneHchrHbpTgeneTchrTbpHLA IIFusionNeoAntigen peptideNeoantigen start (at BP 13)Neoantigen end (at BP 13)
CACNB1-PPP4Cchr1737339966chr16300947151393DRB1-0101IIVYIKITSPKVRYP419
CACNB1-PPP4Cchr1737339966chr16300947151393DRB1-0101PIIVYIKITSPKVRY318
CACNB1-PPP4Cchr1737339966chr16300947151393DRB1-0103IIVYIKITSPKVRYP419
CACNB1-PPP4Cchr1737339966chr16300947151393DRB1-0103PIIVYIKITSPKVRY318
CACNB1-PPP4Cchr1737339966chr16300947151393DRB1-0103IVYIKITSPKVRYPD520
CACNB1-PPP4Cchr1737339966chr16300947151393DRB1-0105IIVYIKITSPKVRYP419
CACNB1-PPP4Cchr1737339966chr16300947151393DRB1-0105PIIVYIKITSPKVRY318
CACNB1-PPP4Cchr1737339966chr16300947151393DRB1-0107IIVYIKITSPKVRYP419
CACNB1-PPP4Cchr1737339966chr16300947151393DRB1-0107PIIVYIKITSPKVRY318
CACNB1-PPP4Cchr1737339966chr16300947151393DRB1-0109IIVYIKITSPKVRYP419
CACNB1-PPP4Cchr1737339966chr16300947151393DRB1-0109PIIVYIKITSPKVRY318
CACNB1-PPP4Cchr1737339966chr16300947151393DRB1-0109IVYIKITSPKVRYPD520
CACNB1-PPP4Cchr1737339966chr16300947151393DRB1-0111IIVYIKITSPKVRYP419
CACNB1-PPP4Cchr1737339966chr16300947151393DRB1-0111PIIVYIKITSPKVRY318
CACNB1-PPP4Cchr1737339966chr16300947151393DRB1-0111IVYIKITSPKVRYPD520
CACNB1-PPP4Cchr1737339966chr16300947151393DRB1-0113IIVYIKITSPKVRYP419
CACNB1-PPP4Cchr1737339966chr16300947151393DRB1-0113PIIVYIKITSPKVRY318
CACNB1-PPP4Cchr1737339966chr16300947151393DRB1-0113IVYIKITSPKVRYPD520
CACNB1-PPP4Cchr1737339966chr16300947151393DRB1-0113APIIVYIKITSPKVR217
CACNB1-PPP4Cchr1737339966chr16300947151393DRB1-0115IIVYIKITSPKVRYP419
CACNB1-PPP4Cchr1737339966chr16300947151393DRB1-0115PIIVYIKITSPKVRY318
CACNB1-PPP4Cchr1737339966chr16300947151393DRB1-0115IVYIKITSPKVRYPD520
CACNB1-PPP4Cchr1737339966chr16300947151393DRB1-0117IIVYIKITSPKVRYP419
CACNB1-PPP4Cchr1737339966chr16300947151393DRB1-0117PIIVYIKITSPKVRY318
CACNB1-PPP4Cchr1737339966chr16300947151393DRB1-0117IVYIKITSPKVRYPD520
CACNB1-PPP4Cchr1737339966chr16300947151393DRB1-0119IIVYIKITSPKVRYP419
CACNB1-PPP4Cchr1737339966chr16300947151393DRB1-0119PIIVYIKITSPKVRY318
CACNB1-PPP4Cchr1737339966chr16300947151393DRB1-0121IIVYIKITSPKVRYP419
CACNB1-PPP4Cchr1737339966chr16300947151393DRB1-0121PIIVYIKITSPKVRY318
CACNB1-PPP4Cchr1737339966chr16300947151393DRB1-0121IVYIKITSPKVRYPD520
CACNB1-PPP4Cchr1737339966chr16300947151393DRB1-0125IIVYIKITSPKVRYP419
CACNB1-PPP4Cchr1737339966chr16300947151393DRB1-0125PIIVYIKITSPKVRY318
CACNB1-PPP4Cchr1737339966chr16300947151393DRB1-0127IIVYIKITSPKVRYP419
CACNB1-PPP4Cchr1737339966chr16300947151393DRB1-0127PIIVYIKITSPKVRY318
CACNB1-PPP4Cchr1737339966chr16300947151393DRB1-0129IIVYIKITSPKVRYP419
CACNB1-PPP4Cchr1737339966chr16300947151393DRB1-0129PIIVYIKITSPKVRY318
CACNB1-PPP4Cchr1737339966chr16300947151393DRB1-0129IVYIKITSPKVRYPD520
CACNB1-PPP4Cchr1737339966chr16300947151393DRB1-0131IIVYIKITSPKVRYP419
CACNB1-PPP4Cchr1737339966chr16300947151393DRB1-0131PIIVYIKITSPKVRY318
CACNB1-PPP4Cchr1737339966chr16300947151393DRB1-0447IIVYIKITSPKVRYP419
CACNB1-PPP4Cchr1737339966chr16300947151393DRB1-0469IIVYIKITSPKVRYP419
CACNB1-PPP4Cchr1737339966chr16300947151393DRB1-0482IIVYIKITSPKVRYP419
CACNB1-PPP4Cchr1737339966chr16300947151393DRB1-0482PIIVYIKITSPKVRY318
CACNB1-PPP4Cchr1737339966chr16300947151393DRB1-0701IIVYIKITSPKVRYP419
CACNB1-PPP4Cchr1737339966chr16300947151393DRB1-0701PIIVYIKITSPKVRY318
CACNB1-PPP4Cchr1737339966chr16300947151393DRB1-0701APIIVYIKITSPKVR217
CACNB1-PPP4Cchr1737339966chr16300947151393DRB1-0703IIVYIKITSPKVRYP419
CACNB1-PPP4Cchr1737339966chr16300947151393DRB1-0703PIIVYIKITSPKVRY318
CACNB1-PPP4Cchr1737339966chr16300947151393DRB1-0703APIIVYIKITSPKVR217
CACNB1-PPP4Cchr1737339966chr16300947151393DRB1-0704IIVYIKITSPKVRYP419
CACNB1-PPP4Cchr1737339966chr16300947151393DRB1-0704PIIVYIKITSPKVRY318
CACNB1-PPP4Cchr1737339966chr16300947151393DRB1-0704IVYIKITSPKVRYPD520
CACNB1-PPP4Cchr1737339966chr16300947151393DRB1-0704APIIVYIKITSPKVR217
CACNB1-PPP4Cchr1737339966chr16300947151393DRB1-0705IIVYIKITSPKVRYP419
CACNB1-PPP4Cchr1737339966chr16300947151393DRB1-0705PIIVYIKITSPKVRY318
CACNB1-PPP4Cchr1737339966chr16300947151393DRB1-0705APIIVYIKITSPKVR217
CACNB1-PPP4Cchr1737339966chr16300947151393DRB1-0706IIVYIKITSPKVRYP419
CACNB1-PPP4Cchr1737339966chr16300947151393DRB1-0706PIIVYIKITSPKVRY318
CACNB1-PPP4Cchr1737339966chr16300947151393DRB1-0706APIIVYIKITSPKVR217
CACNB1-PPP4Cchr1737339966chr16300947151393DRB1-0706IVYIKITSPKVRYPD520
CACNB1-PPP4Cchr1737339966chr16300947151393DRB1-0707IIVYIKITSPKVRYP419
CACNB1-PPP4Cchr1737339966chr16300947151393DRB1-0707PIIVYIKITSPKVRY318
CACNB1-PPP4Cchr1737339966chr16300947151393DRB1-0707APIIVYIKITSPKVR217
CACNB1-PPP4Cchr1737339966chr16300947151393DRB1-0708IIVYIKITSPKVRYP419
CACNB1-PPP4Cchr1737339966chr16300947151393DRB1-0708PIIVYIKITSPKVRY318
CACNB1-PPP4Cchr1737339966chr16300947151393DRB1-0708APIIVYIKITSPKVR217
CACNB1-PPP4Cchr1737339966chr16300947151393DRB1-0709IIVYIKITSPKVRYP419
CACNB1-PPP4Cchr1737339966chr16300947151393DRB1-0709PIIVYIKITSPKVRY318
CACNB1-PPP4Cchr1737339966chr16300947151393DRB1-0709APIIVYIKITSPKVR217
CACNB1-PPP4Cchr1737339966chr16300947151393DRB1-0711IIVYIKITSPKVRYP419
CACNB1-PPP4Cchr1737339966chr16300947151393DRB1-0711PIIVYIKITSPKVRY318
CACNB1-PPP4Cchr1737339966chr16300947151393DRB1-0711APIIVYIKITSPKVR217
CACNB1-PPP4Cchr1737339966chr16300947151393DRB1-0711IVYIKITSPKVRYPD520
CACNB1-PPP4Cchr1737339966chr16300947151393DRB1-0712IIVYIKITSPKVRYP419
CACNB1-PPP4Cchr1737339966chr16300947151393DRB1-0712PIIVYIKITSPKVRY318
CACNB1-PPP4Cchr1737339966chr16300947151393DRB1-0712APIIVYIKITSPKVR217
CACNB1-PPP4Cchr1737339966chr16300947151393DRB1-0713IIVYIKITSPKVRYP419
CACNB1-PPP4Cchr1737339966chr16300947151393DRB1-0713PIIVYIKITSPKVRY318
CACNB1-PPP4Cchr1737339966chr16300947151393DRB1-0713APIIVYIKITSPKVR217
CACNB1-PPP4Cchr1737339966chr16300947151393DRB1-0714IIVYIKITSPKVRYP419
CACNB1-PPP4Cchr1737339966chr16300947151393DRB1-0714PIIVYIKITSPKVRY318
CACNB1-PPP4Cchr1737339966chr16300947151393DRB1-0714APIIVYIKITSPKVR217
CACNB1-PPP4Cchr1737339966chr16300947151393DRB1-0715IIVYIKITSPKVRYP419
CACNB1-PPP4Cchr1737339966chr16300947151393DRB1-0715PIIVYIKITSPKVRY318
CACNB1-PPP4Cchr1737339966chr16300947151393DRB1-0715APIIVYIKITSPKVR217
CACNB1-PPP4Cchr1737339966chr16300947151393DRB1-0716IIVYIKITSPKVRYP419
CACNB1-PPP4Cchr1737339966chr16300947151393DRB1-0716PIIVYIKITSPKVRY318
CACNB1-PPP4Cchr1737339966chr16300947151393DRB1-0716APIIVYIKITSPKVR217
CACNB1-PPP4Cchr1737339966chr16300947151393DRB1-0717IIVYIKITSPKVRYP419
CACNB1-PPP4Cchr1737339966chr16300947151393DRB1-0717PIIVYIKITSPKVRY318
CACNB1-PPP4Cchr1737339966chr16300947151393DRB1-0717APIIVYIKITSPKVR217
CACNB1-PPP4Cchr1737339966chr16300947151393DRB1-0719IIVYIKITSPKVRYP419
CACNB1-PPP4Cchr1737339966chr16300947151393DRB1-0719PIIVYIKITSPKVRY318
CACNB1-PPP4Cchr1737339966chr16300947151393DRB1-0719APIIVYIKITSPKVR217
CACNB1-PPP4Cchr1737339966chr16300947151393DRB1-0807IIVYIKITSPKVRYP419
CACNB1-PPP4Cchr1737339966chr16300947151393DRB1-0819IIVYIKITSPKVRYP419
CACNB1-PPP4Cchr1737339966chr16300947151393DRB1-0819PIIVYIKITSPKVRY318
CACNB1-PPP4Cchr1737339966chr16300947151393DRB1-0819APIIVYIKITSPKVR217
CACNB1-PPP4Cchr1737339966chr16300947151393DRB1-0825IIVYIKITSPKVRYP419
CACNB1-PPP4Cchr1737339966chr16300947151393DRB1-0825PIIVYIKITSPKVRY318
CACNB1-PPP4Cchr1737339966chr16300947151393DRB1-0825APIIVYIKITSPKVR217
CACNB1-PPP4Cchr1737339966chr16300947151393DRB1-0832IIVYIKITSPKVRYP419
CACNB1-PPP4Cchr1737339966chr16300947151393DRB1-0834IIVYIKITSPKVRYP419
CACNB1-PPP4Cchr1737339966chr16300947151393DRB1-0834PIIVYIKITSPKVRY318
CACNB1-PPP4Cchr1737339966chr16300947151393DRB1-0834APIIVYIKITSPKVR217
CACNB1-PPP4Cchr1737339966chr16300947151393DRB1-1130IIVYIKITSPKVRYP419
CACNB1-PPP4Cchr1737339966chr16300947151393DRB1-1216IIVYIKITSPKVRYP419
CACNB1-PPP4Cchr1737339966chr16300947151393DRB1-1216PIIVYIKITSPKVRY318
CACNB1-PPP4Cchr1737339966chr16300947151393DRB1-1222IIVYIKITSPKVRYP419
CACNB1-PPP4Cchr1737339966chr16300947151393DRB1-1222PIIVYIKITSPKVRY318
CACNB1-PPP4Cchr1737339966chr16300947151393DRB1-1222APIIVYIKITSPKVR217
CACNB1-PPP4Cchr1737339966chr16300947151393DRB1-1222IVYIKITSPKVRYPD520
CACNB1-PPP4Cchr1737339966chr16300947151393DRB1-13100IIVYIKITSPKVRYP419
CACNB1-PPP4Cchr1737339966chr16300947151393DRB1-1346IIVYIKITSPKVRYP419
CACNB1-PPP4Cchr1737339966chr16300947151393DRB1-1367IIVYIKITSPKVRYP419
CACNB1-PPP4Cchr1737339966chr16300947151393DRB1-1402IIVYIKITSPKVRYP419
CACNB1-PPP4Cchr1737339966chr16300947151393DRB1-1424IIVYIKITSPKVRYP419
CACNB1-PPP4Cchr1737339966chr16300947151393DRB1-1441IIVYIKITSPKVRYP419
CACNB1-PPP4Cchr1737339966chr16300947151393DRB1-1446IIVYIKITSPKVRYP419
CACNB1-PPP4Cchr1737339966chr16300947151393DRB1-1446PIIVYIKITSPKVRY318
CACNB1-PPP4Cchr1737339966chr16300947151393DRB1-1446IVYIKITSPKVRYPD520
CACNB1-PPP4Cchr1737339966chr16300947151393DRB1-1446APIIVYIKITSPKVR217
CACNB1-PPP4Cchr1737339966chr16300947151393DRB1-1448IIVYIKITSPKVRYP419
CACNB1-PPP4Cchr1737339966chr16300947151393DRB1-1448PIIVYIKITSPKVRY318
CACNB1-PPP4Cchr1737339966chr16300947151393DRB1-1449IIVYIKITSPKVRYP419
CACNB1-PPP4Cchr1737339966chr16300947151393DRB1-1452APIIVYIKITSPKVR217
CACNB1-PPP4Cchr1737339966chr16300947151393DRB1-1489IIVYIKITSPKVRYP419
CACNB1-PPP4Cchr1737339966chr16300947151393DRB1-1494IIVYIKITSPKVRYP419
CACNB1-PPP4Cchr1737339966chr16300947151393DRB1-1502IIVYIKITSPKVRYP419
CACNB1-PPP4Cchr1737339966chr16300947151393DRB1-1502PIIVYIKITSPKVRY318
CACNB1-PPP4Cchr1737339966chr16300947151393DRB1-1502IVYIKITSPKVRYPD520
CACNB1-PPP4Cchr1737339966chr16300947151393DRB1-1508IIVYIKITSPKVRYP419
CACNB1-PPP4Cchr1737339966chr16300947151393DRB1-1508PIIVYIKITSPKVRY318
CACNB1-PPP4Cchr1737339966chr16300947151393DRB1-1508IVYIKITSPKVRYPD520
CACNB1-PPP4Cchr1737339966chr16300947151393DRB1-1511IIVYIKITSPKVRYP419
CACNB1-PPP4Cchr1737339966chr16300947151393DRB1-1511PIIVYIKITSPKVRY318
CACNB1-PPP4Cchr1737339966chr16300947151393DRB1-1511IVYIKITSPKVRYPD520
CACNB1-PPP4Cchr1737339966chr16300947151393DRB1-1511APIIVYIKITSPKVR217
CACNB1-PPP4Cchr1737339966chr16300947151393DRB1-1514IIVYIKITSPKVRYP419
CACNB1-PPP4Cchr1737339966chr16300947151393DRB1-1514PIIVYIKITSPKVRY318
CACNB1-PPP4Cchr1737339966chr16300947151393DRB1-1514IVYIKITSPKVRYPD520
CACNB1-PPP4Cchr1737339966chr16300947151393DRB1-1515IIVYIKITSPKVRYP419
CACNB1-PPP4Cchr1737339966chr16300947151393DRB1-1515PIIVYIKITSPKVRY318
CACNB1-PPP4Cchr1737339966chr16300947151393DRB1-1515IVYIKITSPKVRYPD520
CACNB1-PPP4Cchr1737339966chr16300947151393DRB1-1515APIIVYIKITSPKVR217
CACNB1-PPP4Cchr1737339966chr16300947151393DRB1-1519IIVYIKITSPKVRYP419
CACNB1-PPP4Cchr1737339966chr16300947151393DRB1-1519PIIVYIKITSPKVRY318
CACNB1-PPP4Cchr1737339966chr16300947151393DRB1-1519IVYIKITSPKVRYPD520
CACNB1-PPP4Cchr1737339966chr16300947151393DRB1-1526IIVYIKITSPKVRYP419
CACNB1-PPP4Cchr1737339966chr16300947151393DRB1-1526PIIVYIKITSPKVRY318
CACNB1-PPP4Cchr1737339966chr16300947151393DRB1-1526IVYIKITSPKVRYPD520
CACNB1-PPP4Cchr1737339966chr16300947151393DRB1-1527IIVYIKITSPKVRYP419
CACNB1-PPP4Cchr1737339966chr16300947151393DRB1-1527PIIVYIKITSPKVRY318
CACNB1-PPP4Cchr1737339966chr16300947151393DRB1-1527IVYIKITSPKVRYPD520
CACNB1-PPP4Cchr1737339966chr16300947151393DRB1-1527APIIVYIKITSPKVR217
CACNB1-PPP4Cchr1737339966chr16300947151393DRB1-1529IIVYIKITSPKVRYP419
CACNB1-PPP4Cchr1737339966chr16300947151393DRB1-1529PIIVYIKITSPKVRY318
CACNB1-PPP4Cchr1737339966chr16300947151393DRB1-1530IIVYIKITSPKVRYP419
CACNB1-PPP4Cchr1737339966chr16300947151393DRB1-1530PIIVYIKITSPKVRY318
CACNB1-PPP4Cchr1737339966chr16300947151393DRB1-1531IIVYIKITSPKVRYP419
CACNB1-PPP4Cchr1737339966chr16300947151393DRB1-1531PIIVYIKITSPKVRY318
CACNB1-PPP4Cchr1737339966chr16300947151393DRB1-1531IVYIKITSPKVRYPD520
CACNB1-PPP4Cchr1737339966chr16300947151393DRB1-1531APIIVYIKITSPKVR217
CACNB1-PPP4Cchr1737339966chr16300947151393DRB1-1534IIVYIKITSPKVRYP419
CACNB1-PPP4Cchr1737339966chr16300947151393DRB1-1534PIIVYIKITSPKVRY318
CACNB1-PPP4Cchr1737339966chr16300947151393DRB1-1534IVYIKITSPKVRYPD520
CACNB1-PPP4Cchr1737339966chr16300947151393DRB1-1534APIIVYIKITSPKVR217
CACNB1-PPP4Cchr1737339966chr16300947151393DRB1-1538IIVYIKITSPKVRYP419
CACNB1-PPP4Cchr1737339966chr16300947151393DRB1-1538PIIVYIKITSPKVRY318
CACNB1-PPP4Cchr1737339966chr16300947151393DRB1-1538IVYIKITSPKVRYPD520
CACNB1-PPP4Cchr1737339966chr16300947151393DRB1-1539IIVYIKITSPKVRYP419
CACNB1-PPP4Cchr1737339966chr16300947151393DRB1-1539PIIVYIKITSPKVRY318
CACNB1-PPP4Cchr1737339966chr16300947151393DRB1-1539IVYIKITSPKVRYPD520
CACNB1-PPP4Cchr1737339966chr16300947151393DRB1-1544IIVYIKITSPKVRYP419
CACNB1-PPP4Cchr1737339966chr16300947151393DRB1-1544PIIVYIKITSPKVRY318
CACNB1-PPP4Cchr1737339966chr16300947151393DRB1-1544IVYIKITSPKVRYPD520
CACNB1-PPP4Cchr1737339966chr16300947151393DRB1-1547IIVYIKITSPKVRYP419
CACNB1-PPP4Cchr1737339966chr16300947151393DRB1-1547PIIVYIKITSPKVRY318
CACNB1-PPP4Cchr1737339966chr16300947151393DRB1-1547IVYIKITSPKVRYPD520
CACNB1-PPP4Cchr1737339966chr16300947151393DRB1-1601IIVYIKITSPKVRYP419
CACNB1-PPP4Cchr1737339966chr16300947151393DRB1-1601PIIVYIKITSPKVRY318
CACNB1-PPP4Cchr1737339966chr16300947151393DRB1-1601IVYIKITSPKVRYPD520
CACNB1-PPP4Cchr1737339966chr16300947151393DRB1-1601APIIVYIKITSPKVR217
CACNB1-PPP4Cchr1737339966chr16300947151393DRB1-1602IIVYIKITSPKVRYP419
CACNB1-PPP4Cchr1737339966chr16300947151393DRB1-1602PIIVYIKITSPKVRY318
CACNB1-PPP4Cchr1737339966chr16300947151393DRB1-1602IVYIKITSPKVRYPD520
CACNB1-PPP4Cchr1737339966chr16300947151393DRB1-1602APIIVYIKITSPKVR217
CACNB1-PPP4Cchr1737339966chr16300947151393DRB1-1603IIVYIKITSPKVRYP419
CACNB1-PPP4Cchr1737339966chr16300947151393DRB1-1603PIIVYIKITSPKVRY318
CACNB1-PPP4Cchr1737339966chr16300947151393DRB1-1603IVYIKITSPKVRYPD520
CACNB1-PPP4Cchr1737339966chr16300947151393DRB1-1603APIIVYIKITSPKVR217
CACNB1-PPP4Cchr1737339966chr16300947151393DRB1-1604IIVYIKITSPKVRYP419
CACNB1-PPP4Cchr1737339966chr16300947151393DRB1-1604PIIVYIKITSPKVRY318
CACNB1-PPP4Cchr1737339966chr16300947151393DRB1-1604IVYIKITSPKVRYPD520
CACNB1-PPP4Cchr1737339966chr16300947151393DRB1-1604APIIVYIKITSPKVR217
CACNB1-PPP4Cchr1737339966chr16300947151393DRB1-1605IIVYIKITSPKVRYP419
CACNB1-PPP4Cchr1737339966chr16300947151393DRB1-1605PIIVYIKITSPKVRY318
CACNB1-PPP4Cchr1737339966chr16300947151393DRB1-1605IVYIKITSPKVRYPD520
CACNB1-PPP4Cchr1737339966chr16300947151393DRB1-1605APIIVYIKITSPKVR217
CACNB1-PPP4Cchr1737339966chr16300947151393DRB1-1607IIVYIKITSPKVRYP419
CACNB1-PPP4Cchr1737339966chr16300947151393DRB1-1607PIIVYIKITSPKVRY318
CACNB1-PPP4Cchr1737339966chr16300947151393DRB1-1607IVYIKITSPKVRYPD520
CACNB1-PPP4Cchr1737339966chr16300947151393DRB1-1607APIIVYIKITSPKVR217
CACNB1-PPP4Cchr1737339966chr16300947151393DRB1-1608IIVYIKITSPKVRYP419
CACNB1-PPP4Cchr1737339966chr16300947151393DRB1-1608PIIVYIKITSPKVRY318
CACNB1-PPP4Cchr1737339966chr16300947151393DRB1-1608IVYIKITSPKVRYPD520
CACNB1-PPP4Cchr1737339966chr16300947151393DRB1-1608APIIVYIKITSPKVR217
CACNB1-PPP4Cchr1737339966chr16300947151393DRB1-1609IIVYIKITSPKVRYP419
CACNB1-PPP4Cchr1737339966chr16300947151393DRB1-1609PIIVYIKITSPKVRY318
CACNB1-PPP4Cchr1737339966chr16300947151393DRB1-1609IVYIKITSPKVRYPD520
CACNB1-PPP4Cchr1737339966chr16300947151393DRB1-1609APIIVYIKITSPKVR217
CACNB1-PPP4Cchr1737339966chr16300947151393DRB1-1610IIVYIKITSPKVRYP419
CACNB1-PPP4Cchr1737339966chr16300947151393DRB1-1610PIIVYIKITSPKVRY318
CACNB1-PPP4Cchr1737339966chr16300947151393DRB1-1610IVYIKITSPKVRYPD520
CACNB1-PPP4Cchr1737339966chr16300947151393DRB1-1610APIIVYIKITSPKVR217
CACNB1-PPP4Cchr1737339966chr16300947151393DRB1-1611IIVYIKITSPKVRYP419
CACNB1-PPP4Cchr1737339966chr16300947151393DRB1-1611PIIVYIKITSPKVRY318
CACNB1-PPP4Cchr1737339966chr16300947151393DRB1-1611IVYIKITSPKVRYPD520
CACNB1-PPP4Cchr1737339966chr16300947151393DRB1-1611APIIVYIKITSPKVR217
CACNB1-PPP4Cchr1737339966chr16300947151393DRB1-1612IIVYIKITSPKVRYP419
CACNB1-PPP4Cchr1737339966chr16300947151393DRB1-1612PIIVYIKITSPKVRY318
CACNB1-PPP4Cchr1737339966chr16300947151393DRB1-1612IVYIKITSPKVRYPD520
CACNB1-PPP4Cchr1737339966chr16300947151393DRB1-1612APIIVYIKITSPKVR217
CACNB1-PPP4Cchr1737339966chr16300947151393DRB1-1614IIVYIKITSPKVRYP419
CACNB1-PPP4Cchr1737339966chr16300947151393DRB1-1614PIIVYIKITSPKVRY318
CACNB1-PPP4Cchr1737339966chr16300947151393DRB1-1614IVYIKITSPKVRYPD520
CACNB1-PPP4Cchr1737339966chr16300947151393DRB1-1614APIIVYIKITSPKVR217
CACNB1-PPP4Cchr1737339966chr16300947151393DRB1-1615IIVYIKITSPKVRYP419
CACNB1-PPP4Cchr1737339966chr16300947151393DRB1-1616IIVYIKITSPKVRYP419
CACNB1-PPP4Cchr1737339966chr16300947151393DRB1-1616PIIVYIKITSPKVRY318
CACNB1-PPP4Cchr1737339966chr16300947151393DRB1-1616IVYIKITSPKVRYPD520
CACNB1-PPP4Cchr1737339966chr16300947151393DRB1-1616APIIVYIKITSPKVR217
CACNB1-PPP4Cchr1737339966chr16300947151393DRB3-0215IIVYIKITSPKVRYP419
CACNB1-PPP4Cchr1737339966chr16300947151393DRB5-0102IIVYIKITSPKVRYP419
CACNB1-PPP4Cchr1737339966chr16300947151393DRB5-0103IIVYIKITSPKVRYP419
CACNB1-PPP4Cchr1737339966chr16300947151393DRB5-0104IIVYIKITSPKVRYP419
CACNB1-PPP4Cchr1737339966chr16300947151393DRB5-0104IVYIKITSPKVRYPD520
CACNB1-PPP4Cchr1737339966chr16300947151393DRB5-0106IVYIKITSPKVRYPD520
CACNB1-PPP4Cchr1737339966chr16300947151393DRB5-0106IIVYIKITSPKVRYP419
CACNB1-PPP4Cchr1737339966chr16300947151393DRB5-0108NIIVYIKITSPKVRYP419
CACNB1-PPP4Cchr1737339966chr16300947151393DRB5-0111IIVYIKITSPKVRYP419
CACNB1-PPP4Cchr1737339966chr16300947151393DRB5-0111IVYIKITSPKVRYPD520
CACNB1-PPP4Cchr1737339966chr16300947151393DRB5-0112IIVYIKITSPKVRYP419
CACNB1-PPP4Cchr1737339966chr16300947151393DRB5-0112IVYIKITSPKVRYPD520
CACNB1-PPP4Cchr1737339966chr16300947151393DRB5-0202IVYIKITSPKVRYPD520
CACNB1-PPP4Cchr1737339966chr16300947151393DRB5-0203IIVYIKITSPKVRYP419
CACNB1-PPP4Cchr1737339966chr16300947151393DRB5-0204IVYIKITSPKVRYPD520
CACNB1-PPP4Cchr1737339966chr16300947151393DRB5-0205IVYIKITSPKVRYPD520

Top

Fusion breakpoint peptide structures of CACNB1-PPP4C

check button3D structures of the fusion breakpoint peptide of 14AA sequence that have potential fusion neoantigens
* The minimum length of the amino acid sequence in RoseTTAFold is 14AA. Here, we predicted the 14AA fusion protein breakpoint sequence not the fusion neoantigen peptide, which is shorter than 14 AA.
File nameBPseqHgeneTgeneHchrHbpTchrTbpAAlen
10399VYIKITSPKVRYPDCACNB1PPP4Cchr1737339966chr16300947151393

Top

Filtering FusionNeoAntigens Through Checking the Interaction with HLAs in 3D of CACNB1-PPP4C

check buttonVirtual screening between 25 HLAs (from PDB) and FusionNeoAntigens
* We used Glide to predict the interaction between HLAs and neoantigens.
HLA allelePDB IDFile nameBPseqDocking scoreGlide score
HLA-B14:023BVN10399VYIKITSPKVRYPD-7.15543-7.26883
HLA-B14:023BVN10399VYIKITSPKVRYPD-4.77435-5.80965
HLA-B52:013W3910399VYIKITSPKVRYPD-6.80875-6.92215
HLA-B52:013W3910399VYIKITSPKVRYPD-4.20386-5.23916
HLA-A11:014UQ210399VYIKITSPKVRYPD-7.5194-8.5547
HLA-A11:014UQ210399VYIKITSPKVRYPD-6.9601-7.0735
HLA-A24:025HGA10399VYIKITSPKVRYPD-7.52403-7.63743
HLA-A24:025HGA10399VYIKITSPKVRYPD-5.82433-6.85963
HLA-B27:056PYJ10399VYIKITSPKVRYPD-3.28285-4.31815
HLA-B44:053DX810399VYIKITSPKVRYPD-5.91172-6.94702
HLA-B44:053DX810399VYIKITSPKVRYPD-4.24346-4.35686
HLA-B35:011A1N10399VYIKITSPKVRYPD-5.9251-6.0385
HLA-B35:011A1N10399VYIKITSPKVRYPD-4.80237-5.83767

Top

Vaccine Design for the FusionNeoAntigens of CACNB1-PPP4C

check button mRNA and peptide sequences of FusionNeoAntigens that have potential interaction with HLA-Is.
Fusion geneHchrHbpTchrTbpStart in +/-13AAEnd in +/-13AAFusionNeoAntigen peptide sequenceFusionNeoAntigen RNA sequence
CACNB1-PPP4Cchr1737339966chr16300947151018ITSPKVRYTCTCCCAAGGTTCGCTATCCTGAT
CACNB1-PPP4Cchr1737339966chr1630094715615VYIKITSPKATCAAGATCACCTCTCCCAAGGTTCGC
CACNB1-PPP4Cchr1737339966chr1630094715617VYIKITSPKVRATCAAGATCACCTCTCCCAAGGTTCGCTATCCT
CACNB1-PPP4Cchr1737339966chr1630094715716YIKITSPKVAAGATCACCTCTCCCAAGGTTCGCTAT
CACNB1-PPP4Cchr1737339966chr1630094715818IKITSPKVRYATCACCTCTCCCAAGGTTCGCTATCCTGAT
CACNB1-PPP4Cchr1737339966chr1630094715918KITSPKVRYACCTCTCCCAAGGTTCGCTATCCTGAT

check button mRNA and peptide sequences of FusionNeoAntigens that have potential interaction with HLA-IIs.
Fusion geneHchrHbpTchrTbpStart in +/-13AAEnd in +/-13AAFusionNeoAntigen peptideFusionNEoAntigen RNA sequence
CACNB1-PPP4Cchr1737339966chr1630094715217APIIVYIKITSPKVRATCATTGTTTACATCAAGATCACCTCTCCCAAGGTTCGCTATCCT
CACNB1-PPP4Cchr1737339966chr1630094715318PIIVYIKITSPKVRYATTGTTTACATCAAGATCACCTCTCCCAAGGTTCGCTATCCTGAT
CACNB1-PPP4Cchr1737339966chr1630094715419IIVYIKITSPKVRYPGTTTACATCAAGATCACCTCTCCCAAGGTTCGCTATCCTGATCGC
CACNB1-PPP4Cchr1737339966chr1630094715520IVYIKITSPKVRYPDTACATCAAGATCACCTCTCCCAAGGTTCGCTATCCTGATCGCATC

Top

Information of the samples that have these potential fusion neoantigens of CACNB1-PPP4C

check button These samples were reported as having these fusion breakpoints. For individual breakpoints, we checked the open reading frames considering multiple gene isoforms and chose the in-frame fusion genes only. Then, we made fusion protein sequences and predicted the fusion neoantigens. These fusion-positive samples may have these potential fusion neoantigens.
Cancer typeFusion geneHchrHbpHenstTchrTbpTenstSample
BRCACACNB1-PPP4Cchr1737339966ENST00000344140chr1630094715ENST00000279387TCGA-C8-A135-01A

Top

Potential target of CAR-T therapy development for CACNB1-PPP4C

check button Predicted 3D structure. We used RoseTTAFold.

check buttonRetention analysis result of each fusion partner protein across 39 protein features of UniProt such as six molecule processing features, 13 region features, four site features, six amino acid modification features, two natural variation features, five experimental info features, and 3 secondary structure features. Here, to provide the retention of the transmembrane domain, we only show the protein feature retention information of those transmembrane features


* Minus value of BPloci means that the break point is located before the CDS.
- In-frame and retained 'Transmembrane'.
PartnerGeneHbpTbpENSTStrandBPexonTotalExonProtein feature loci*BPlociTotalLenProtein featureProtein feature note

check button Subcellular localization prediction of the transmembrane domain retained fusion proteins
* We used DeepLoc 1.0. The order of the X-axis of the barplot is as follows: Entry_ID, Localization, Type, Nucleus, Cytoplasm, Extracellular, Mitochondrion, Cell_membrane, Endoplasmic_reticulum, Plastid, Golgi.apparatus, Lysosome.Vacuole, Peroxisome. Y-axis is the output score of DeepLoc. Clicking the image will open a new tab with a large image.
HgeneHchrHbpHenstTgeneTchrTbpTenstDeepLoc result

Top

Related Drugs to CACNB1-PPP4C

check button Drugs used for this fusion-positive patient.
(Manual curation of PubMed, 04-30-2022 + MyCancerGenome)
HgeneTgeneDrugSourcePMID

Top

Related Diseases to CACNB1-PPP4C

check button Diseases that have this fusion gene.
(Manual curation of PubMed, 04-30-2022 + MyCancerGenome)
HgeneTgeneDiseaseSourcePMID

check button Diseases associated with fusion partners.
(DisGeNet 4.0)
PartnerGeneDisease IDDisease name# pubmedsSource